Research at Radial

Backed by research.
Driven by care.

Radial clinicians don't just follow the research, they conduct it. From neuromodulation to digital psychiatry, our team actively publishes and participates in clinical trials, ensuring every patient receives care that is grounded in the best available evidence.

Publications

Nov 2023
Ketamine Monitoring
Evaluating passive physiological data collection during Spravato treatment
Todd M Solomon, Matus Hajduk, Martin Majernik, Jamileh Jemison, Alexander Deschamps, Jenna Scoggins, Adam Kolar, Miguel Amável Pinheiro, Peter Dubec, Ondrej Skala, Owen Muir, Amanda Tinkelman, Daniel R Karlin, Robert Barrow
Spravato sessions generate rich physiological data — but is anyone capturing it? This study evaluates passive data collection during esketamine treatment, exploring whether wearable monitoring can yield clinically meaningful insights without disrupting care.
Depression
Ketamine Monitoring
Oct 2023
Deep TMS
Real world efficacy and safety of various accelerated deep TMS protocols for major depression
Yiftach Roth, Colleen A Hanlon, Gaby Pell, Samuel Zibman, Tal Harmelech, Owen S Muir, Carlene MacMillan, Tim Prestley, David C Purselle, Thomas Knightly, Aron Tendler
Not all accelerated Deep TMS protocols are created equal — so which works best? This Phase IV analysis compared multiple accelerated dosing schedules in real-world MDD patients, finding strong and comparable efficacy across 2, 3, 5, and 10 sessions per day.
Depression
Deep TMS
Jun 2023
Deep TMS
Deep TMS H1 Coil treatment for depression: Results from a large post marketing data analysis
Aron Tendler, Stephan Goerigk, Samuel Zibman, Salomé Ouaknine, Tal Harmelech, Gaby S Pell, Abraham Zangen, Steven A. Harvey, Geoffrey Grammer, Jimmy Stehberg, Oluremi Adefolarin, Owen Muir, Carlene MacMillan, Diana Ghelber, Walter Duffy, Irakli Mania, Zeeshan Faruqui, Faisal Munasifi, Todd Antin, Frank Padberg, Yiftach Roth
What happens when you look at Deep TMS outcomes across more than a thousand patients in real clinical practice? This large post-marketing analysis confirms high response and remission rates for the H1 coil in community settings, with durable effects.
Depression
Deep TMS
Oct 2022
AI / Digital Psychiatry
Remote monitoring and AI for detecting tardive dyskinesia and improving patient outcomes.
A Sterns, L Larsen, B Grimm, OS Muir
Tardive dyskinesia disrupts lives — and often goes unrecognized until it's advanced. This study examines how remote AI monitoring can detect movement abnormalities earlier, enabling timely clinical response and better long-term patient outcomes.
Movement Disorders
AI / Digital Psychiatry
Sep-Oct 2022
Deep TMS
Remission rates following deep TMS for treatment-resistant OCD
Roman Gersner, Aron Tendler, Mehmet Kemal Arikan, Ryan Vidrine, Geoff Grammer, Owen Müir, Carlene MacMillan, Rebecca Sinclair, Saad Shakir, David Kent, Raul Rodriguez, Nicholas Evangelidis, Deborah Kim, Tal Harmelech, Yiftach Roth
Treatment-resistant OCD can leave patients cycling through failed medication trials for years. This study reports remission rates following Deep TMS for OCD, demonstrating that neuromodulation offers a meaningful path forward for patients who haven't responded to conventional care.
OCD
Deep TMS
Jan-Feb 2022
Deep TMS
Long-term outcomes of a course of deep TMS for treatment-resistant OCD
Tal Harmelech, Aron Tendler, Mehmet Kemal Arikan, Hamide Laçin Çetin, Muhammed Taha Esmeray, Reyhan Ilhan, Ryan Vidrine, Owen Muir, Carlene MacMillan, Rebecca Sinclair, Saad Shakir, David Kent, Nicholas Evangelidis, Yiftach Roth
Relief from OCD matters — but so does how long it lasts. This study tracks long-term outcomes following a course of Deep TMS for treatment-resistant OCD, providing some of the most durable follow-up data available for this intervention.
OCD
Deep TMS
Sep 2021
Mentalizing-Based Therapy
Mental health clinicians’ attitudes toward narcissistic personality disorder.
Owen Muir, Jillian N Weinfeld, Danny Ruiz, Dmitry Ostrovsky, Miguel Fiolhais, Carlene MacMillan
Narcissistic personality disorder is one of psychiatry's most stigmatized diagnoses — even among the clinicians treating it. This study surfaces the attitudes and biases mental health professionals hold toward NPD, with implications for training, diagnosis, and therapeutic alliance.
Personality Disorders
Narcissism
Mentalizing-Based Therapy
May 2021
Deep TMS
Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites
Yiftach Roth, Aron Tendler, Mehmet Kemal Arikan, Ryan Vidrine, David Kent, Owen Muir, Carlene MacMillan, Leah Casuto, Geoffrey Grammer, William Sauve, Kellie Tolin, Steven Harvey, Misty Borst, Robert Rifkin, Manish Sheth, Brandon Cornejo, Raul Rodriguez, Saad Shakir, Taylor Porter, Deborah Kim, Abraham Zangen
Deep TMS for OCD has shown promise in controlled trials — but how does it perform across dozens of real-world clinics? This post-marketing analysis of over 1,000 patients from 22 sites confirms strong efficacy for obsessive-compulsive disorder in routine clinical practice.
OCD
Deep TMS
Nov-Dec 2020
Deep TMS
TMS Treatment With The H1 Coil in Youth Age 10-21 Effective In Ameliorating MDD Symptoms
Owen Muir, Danny Ruiz, Rebecca Abbott-Sinclair, Carlene MacMillan
Depression in young people aged 10 to 21 demands safe, effective options beyond medication. This study demonstrates that TMS with the H1 coil meaningfully reduces depressive symptoms in youth, supporting its clinical use in younger populations.
Depression
Deep TMS
Nov-Dec 2020
Deep TMS
Accelerated And Non-Accelerated dTMS Protocols Both Effective In Treatment Of MDD
Owen Muir, Danny Ruiz, Rebecca Abbott-Sinclair, Carlene MacMillan
Should clinicians choose accelerated or standard dTMS for depression — or does it matter? This study found that both protocols produced effective outcomes in MDD, suggesting treatment scheduling can be adapted to patient needs without compromising results.
Depression
Deep TMS
OCD
Deep TMS
Personality Disorders
Narcissism
Mentalizing-Based Therapy
Personality Disorders
Mentalizing-Based Therapy
Depression
Deep TMS
Depression
Deep TMS
Personality Disorders
Mentalizing-Based Therapy
Personality Disorders
Mentalizing-Based Therapy
Depression
Deep TMS
Movement Disorders
AI / Digital Psychiatry
OCD
Deep TMS
Depression
Deep TMS
Depression
Deep TMS
Depression
Deep TMS
Depression
Ketamine Monitoring
PTSD
Bipolar
TMS
Movement Disorders
AI / Digital Psychiatry
Depression
Accelerated TMS
Movement Disorders
AI / Digital Psychiatry
Depression
Accelerated TMS
OCD
Deep TMS
Depression
Accelerated TMS
Depression
Anxiety
TMS
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Deep TMS
No items found.
Mescaline
Personality Disorders
Mentalizing-Based Therapy
Depression
Accelerated TMS
Depression
Anxiety
Accelerated TMS
Depression
Accelerated TMS
OCD
Deep TMS
Depression
Deep TMS
Depression
Deep TMS
Depression
Accelerated TMS
Depression
Deep TMS
Depression
Accelerated TMS
Depression
Ketamine Therapy
Conditions
Treatments
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Active clinical trials

No items found.

Research team

Dr. Owen Scott Muir

Co-founder & Chief Scientific Officer

MD, DFAACAP

Dual board-certified child, adolescent and adult psychiatrist, and author of the award-winning Frontier Psychiatrists newsletter and podcast

Owen Scott Muir is a dual board-certified psychiatrist pioneering innovative treatments for depression, anxiety, and OCD. When medications and therapy alone aren't enough, he helps patients find hope through evidence-based interventional psychiatry.

Read more

Amna Aslam

Applied Research Specialist

Amna M. Aslam, MBA, MSc, is the Applied Research Specialist at Radial Health and serves as Expert Faculty for the American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3). She provides strategic research expertise in clinical outcomes research, post-marketing evidence generation, and health economics, with a focus on translating real-world data into evidence that informs clinical standard practices, healthcare decision-making, and patient access to innovative neuropsychiatric therapies.


Amna’s work spans the design and oversight of real-world evidence and post-marketing studies, clinical outcomes and patient-reported outcomes, and health economics and outcomes research (HEOR) across interventional psychiatry and neurology. She has led numerous investigator-initiated studies, retrospective analyses, prospective observational studies, and scientific publications evaluating innovative neuropsychiatric therapies. Her expertise includes comparative effectiveness research and health economic evaluations, including cost-effectiveness (CEA), cost-utility (CUA), cost-benefit (CBA), budget impact, and quality-adjusted life year (QALY) analyses. She leverages advanced statistical methodologies using SAS, SPSS, and R to generate robust clinical, economic, and patient-centered evidence that informs value-based healthcare decision-making.


Amna earned her Master of Business Administration and Master of Science in Pharmacy Administration with a concentration in Health Economics and Outcomes Research from St. John's University. She previously contributed to research and market access initiatives at Fermata Health and has served as an Community Affairs and Constituent Laison at her local NYS AssemblyMembers Office. Moreover she has served as adjunct professor and graduate research and teaching assistant at St. John's University. Outside of work, Amna enjoys traveling, trying new restaurants, and learning about the intersection of government and healthcare.

Angelique Lucien

Research Coordinator

Angelique Lucien is a Research Coordinator at Radial, where she supports clinical research focused on advancing innovative treatments in psychiatry and brain health. Her work involves coordinating research studies, engaging participants throughout the research process, ensuring regulatory compliance, and contributing to the collection of high-quality clinical data that helps improve treatment outcomes.


With a strong interest in interventional psychiatry, neuroscience, and mental health research, Angelique is passionate about supporting studies that advance our understanding of psychiatric illness and improve treatment options for patients. She is dedicated to helping ensure that research participants have a positive and supportive experience throughout the research process.


Outside of work, Angelique enjoys traveling, spending time with family and friends, trying new restaurants, and staying active. She is driven by a curiosity about the brain and a commitment to improving the lives of individuals affected by mental illness through research and innovation.

Aleah Goodman

Clinical Research Coordinator & Care Navigator

Aleah Goodman is a Clinical Research Coordinator and Patient Care Navigator with research experience in cognitive psychology and behavioral neuroscience. Her work is driven by a deep interest in the relationship between cognition, mental health, and the development of novel psychiatric treatments. She is particularly drawn to understanding how individuals make sense of themselves and perceive their progress over time, and how these experiences can inform increasingly personalized approaches to treatment.

Aleah supports clinical research in interventional psychiatry, including studies on Transcranial Magnetic Stimulation (TMS) and emerging psychiatric medications and technologies. Drawing on her experience as an Interventional Psychiatry Technician and Patient Care Navigator, she focuses on treatment response and patient-reported outcomes across both real-world and research settings with the goal of translating scientific discoveries into meaningful improvements in patient care.

Nicolas Silva

Clinical Research Coordinator & Interventional Psychiatric Technician

Nicolas Silva is a Clinical Research Coordinator and Intervention Psychiatry Technician passionate about advancing mental health research and care.


He holds a degree in Psychological Sciences from the University of Connecticut and is currently pursuing a Master's in Clinical Social Work — driven by a genuine desire to meet people not just in the data, but in the clinic.

His research interests span two areas he finds deeply connected: the role of faith expression in mental health outcomes, and the expanding frontier of interventional psychiatry treatments such as TMS and Spravato. He believes that understanding what gives people meaning — alongside emerging, evidence-based treatments — is essential to advancing compassionate, whole-person care.

Outside of work, Nicolas finds expression through writing poetry and music, playing guitar, and staying active. Creativity and movement are how he stays grounded — and how he brings a little more humanity into everything he does.

Take the first step and talk to a care navigator.

Your care navigator will explain the process, discuss insurance and costs, and connect you with a clinician to explore today’s most advanced mental health treatments.